瑞珍斯生物 RGNX
$7.62 +$0.24 (+3.25%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $7.62 0.00%
开盘$7.33
昨收$7.38
当日区间$7.33 – $7.87
成交量1.19M
市值$503.85M
市盈率（TTM）–
股息率–
RGNX 相关新闻
匹配 Regenxbio 或代码 RGNX 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $21
- Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $42
- BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $15
- BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $15 正面
- A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45
- Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $18 正面
- Clear Street Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $21 负面
- A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $15 to $32
- Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)
- H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $23 负面
- H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $26
- H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $26 负面
- Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $16
- Baird Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $32 正面
暂无评论——快来第一个聊聊 RGNX。